To demonstrate the non-inferiority of QVA149 110/50 µg o. d. to fluticasone/salmeterol 500/50
µg b. i.d. in terms of trough Forced Expiratory Volume in one second (FEV1) (mean of 23 hours
15 min and 23 hours 45 min post QVA149 dose) following 26 weeks of treatment in patients
with moderate to severe COPD
Minimum age: 40 Years.
Maximum age: N/A.
Gender(s): Both.
Novartis Investigative Site, Buenos Aires C1125ABE, Argentina
Novartis Investigative Site, Cordoba X5016KEH, Argentina
Novartis Investigative Site, Santiago Piso 1, Chile
Novartis Investigative Site, Santiago, Chile
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Beijing 100029, China
Novartis Investigative Site, Beijing 100034, China
Novartis Investigative Site, Beijing 100050, China
Novartis Investigative Site, Beijing 100020, China
Novartis Investigative Site, Chongqing 400037, China
Novartis Investigative Site, Chongqing 400038, China
Novartis Investigative Site, Chongqing 400042, China
Novartis Investigative Site, Jiangyin, China
Novartis Investigative Site, Nanjing, China
Novartis Investigative Site, Shanghai 200080, China
Novartis Investigative Site, Shanghai 200433, China
Novartis Investigative Site, Shanghai 200032, China
Novartis Investigative Site, Kaohsiung 81346, Taiwan
Novartis Investigative Site, Lin-Ko 33305, Taiwan
Novartis Investigative Site, Niaosong Township 83301, Taiwan
Novartis Investigative Site, Taichung 40705, Taiwan
Novartis Investigative Site, Taipei County, Taiwan
Novartis Investigative Site, Beijing, Beijing 100023, China
Novartis Investigative Site, Beijing, Beijing 100730, China
Novartis Investigative Site, Caba, Buenos Aires C1424BSF, Argentina
Novartis Investigative Site, Caba, Buenos Aires B8000XAV, Argentina
Novartis Investigative Site, Caba, Buenos Aires C1056ABJ, Argentina
Novartis Investigative Site, Caba, Buenos Aires C1280AEB, Argentina
Novartis Investigative Site, Caba, Buenos Aires C1425BEN, Argentina
Novartis Investigative Site, Caba, Buenos Aires 1122, Argentina
Novartis Investigative Site, La Plata, Buenos Aires 1900, Argentina
Novartis Investigative Site, Mar del Plata, Buenos Aires 7600, Argentina
Novartis Investigative Site, Rojas, Buenos Aires B2705XAE, Argentina
Novartis Investigative Site, Nanning, Guangxi 530021, China
Novartis Investigative Site, Shijiazhuang, Hebei 050000, China
Novartis Investigative Site, Wuhan, Hubei 430022, China
Novartis Investigative Site, Changsha City, Hunan 410011, China
Novartis Investigative Site, Changsha, Hunan 410003, China
Novartis Investigative Site, Nanjing, Jiangsu 210029, China
Novartis Investigative Site, Suzhou, Jiangsu 215004, China
Novartis Investigative Site, Nanchang, Jiangxi 330006, China
Novartis Investigative Site, Shengyang, Liaoning 110016, China
Novartis Investigative Site, Shenyang, Liaoning, China
Novartis Investigative Site, Santiago, Region Metropolitana, Chile
Novartis Investigative Site, Santiago, Region Metropolitana 8431633, Chile
Novartis Investigative Site, Qingdao, Shandong 266011, China
Novartis Investigative Site, Shanghai, Shanghai 200433, China
Novartis Investigative Site, Xi'an, Shanxi 710032, China
Novartis Investigative Site, Xi'an, Shanxi 710061, China
Novartis Investigative Site, Chengdu, Sichuan 610041, China
Novartis Investigative Site, Taipei, Taiwan, ROC 112, Taiwan
Novartis Investigative Site, San Miguel de Tucuman, Tucuman T4000IFL, Argentina
Novartis Investigative Site, Viña del Mar, Vina del Mar 2520024, Chile
Novartis Investigative Site, Hangzhou, Zhejiang 310003, China
Novartis Investigative Site, Hangzhou, Zhejiang 310006, China
Novartis Investigative Site, Hangzhou, Zhejiang 310016, China